Tumorigenic Mutations in VHL Disrupt Folding In Vivo by Interfering with Chaperonin Binding
Open Access
- 1 November 2003
- journal article
- research article
- Published by Elsevier
- Vol. 12 (5) , 1213-1224
- https://doi.org/10.1016/s1097-2765(03)00423-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The CCT Chaperonin Promotes Activation of the Anaphase-Promoting Complex through the Generation of Functional Cdc20Molecular Cell, 2003
- Review: Cellular Substrates of the Eukaryotic Chaperonin TRiC/CCTJournal of Structural Biology, 2001
- The structural basis of protein folding and its links with human diseasePhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- von Hippel-Lindau disease: Clinical and molecular perspectivesPublished by Elsevier ,2001
- The Hsp70 and Hsp60 Chaperone MachinesCell, 1998
- Software and database for the analysis of mutations in the VHL geneNucleic Acids Research, 1998
- Thermodynamic stability of wild-type and mutant p53 core domainProceedings of the National Academy of Sciences, 1997
- Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase IIScience, 1995
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995
- Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.Proceedings of the National Academy of Sciences, 1995